Showing 2331-2340 of 3329 results for "".
- InMode Launches Embrace RF Facial Contouring Solutionhttps://modernaesthetics.com/news/inmode-launches-embrace-rf-facial-contouring-solution/2472082/InMode Aesthetic Solutions is introducing EmbraceRF to target the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8. InMode says the new facial contouring solution address a tr
- FDA Says No to Evolus' Botox Rivalhttps://modernaesthetics.com/news/fda-says-no-to-evolus-botox-rival/2472089/The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed its estimate for the launch of the drug to the spring of next year. Read more
- Carrie Strom is Allergan's New Senior Vice President, U.S. Medical Aestheticshttps://modernaesthetics.com/news/carrie-strom-is-allergans-new-senior-vice-president-us-medical-aesthetics/2472094/Carrie Strom is Allergan’s new Senior Vice President, U.S. Medical Aesthetics, a portfolio of brands including BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® Collection of Fillers, Natrelle® col
- New Merz Survey Highlights Misconceptions about Tattoo Removalhttps://modernaesthetics.com/news/new-merz-survey-highlights-misconceptions-about-tattoo-removal/2472104/More than four in five adults with (86 percent) and without (82 percent) tattoos have misconceptions about tattoo removal, including confusion regarding side effects, cost and removability, according to a new Merz survey. In addition to not knowing how the process works, many underestimat
- New Line of Laser Systems Now Available from Sensus Healthcarehttps://modernaesthetics.com/news/new-line-of-lasers-systems-now-available-from-sensus-healthcare/2472120/Sensus Healthcare, Inc. has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective lasers for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Prior to this launch, the medical device company specialized
- Early Botox May Improve Surgical Scarshttps://modernaesthetics.com/news/early-botox-may-improve-surgical-scars/2472124/Early injections of botulinum toxin A can improve the final appearance of surgical scars, according to a study in the March issue of Plastic
- Body by BTL: New Campaign Showcases Breadth of BTL Aesthetics Offeringshttps://modernaesthetics.com/news/body-by-btl-new-campaign-showcases-breadth-of-btl-aesthetics-offerings/2472134/BTL Aesthetics is celebrating the brand's innovation with a first-of-its-kind campaign for the professional aesthetics industry emphasizing full body results. The Body by
- New AAFPRS Data: Social Media Makes Lasting Impact on Industryhttps://modernaesthetics.com/news/new-aafprs-data-social-media-makes-lasting-impact-on-industry/2472141/Like it or not, the selfie and its impact on aesthetics is here to stay, and continues to have a huge effect on how we perceive and project ourselves in front of the camera and off. This is among the main findings from the annual survey of the
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- Allergan Upgrades Brilliant Distinctions® Patient Loyalty Programhttps://modernaesthetics.com/news/allergan-upgrades-brilliant-distinctions-patient-loyalty-program/2472200/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and dr